Acceptability of drugs for male fertility regulation: a prospectus and some preliminary data. World Health Organization Task Force on Psychosocial Research in Family Planning.
Hormonal substances for male fertility regulation administered orally or by injection are currently undergoing clinical evaluation. These trials, sponsored by the World Health Organization, provide unique opportunities for intensive study of the acceptability of such an approach to fertility regulation, and of these drugs in particular. The research employs repeated interviews over a 15-month period and is conducted by social scientists collaborating with biomedical scientists at each of seven sites (Bangkok, Hong Kong, London, Mexico City, Santiago, Seoul, and Toronto). The focus is upon gauging male user's evaluations of hormonal methods (several androgen/gestagen combinations as well as cyproterone acetate) relative to their evaluations of other male methods they know about or have experienced. Of particular importance is to determine whether the hormonal methods modify or interfere with sexual desire, feelings, and behavior. The research is also assessing specific ways in which various perceived properties of fertility regulating methods relate to their acceptability in different socio-cultural settings.
D000077713:17 alpha-Hydroxyprogesterone Caproate; D002986:Clinical Trials as Topic; D003272:Contraceptive Agents, Male / Q000008:administration & dosage* / Q000494:pharmacology; D003275:Contraceptive Devices, Male; D003534:Cyproterone / Q000008:administration & dosage / Q000031:analogs & derivatives / Q000494:pharmacology; D017373:Cyproterone Acetate; D006801:Humans; D006908:Hydroxyprogesterones / Q000008:administration & dosage / Q000494:pharmacology; D007989:Libido / Q000187:drug effects; D008297:Male; D008525:Medroxyprogesterone / Q000008:administration & dosage / Q000031:analogs & derivatives / Q000494:pharmacology; D017258:Medroxyprogesterone Acetate; D012725:Sexual Behavior; D013739:Testosterone / Q000008:administration & dosage / Q000031:analogs & derivatives / Q000494:pharmacology; D014659:Vasectomy; D014944:World Health Organization
D003272:Contraceptive Agents, Male; D006908:Hydroxyprogesterones; D000077713:17 alpha-Hydroxyprogesterone Caproate; D013739:Testosterone; D017373:Cyproterone Acetate; C004648:testosterone enanthate; D017258:Medroxyprogesterone Acetate; D003534:Cyproterone; D008525:Medroxyprogesterone; C016131:testosterone 17 beta-cypionate